FDA grants fast track designation to Losmapimod
[…] granted Fast Track designation to losmapimod for the potential treatment of facioscapulohumeral muscular dystrophy ( FSHD). “There are no approved therapies to treat patients with FSHD, and losmapimod is currently […]